MEETINGS - In vitro diagnostic devices information day (Eire) September 2001:
This article was originally published in Clinica
The Irish Medicines Board is hosting an In vitro diagnostic devices information day, on September 24 2001, at the Hilton Stakis Hotel, Dublin. The meeting will look at issues such as the new registration system for IVD devices, the vigilance and recall system, technical specifications, and free sale certificates, among others. It will also serve to introduce to the industry the medical devices department of the IMB, following its designation last month as Competent Authority. For more information tel: +353 1 676 4971-5; fax +353 1 676 7836; email: email@example.com
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.